Home › Funds › Q Fund Management (Hong Kong) Ltd › DNA

Q Fund Management (Hong Kong) Ltd position in DNA

GINKGO BIOWORKS HOLDINGS INC · Health Care

Q Fund Management (Hong Kong) Ltd reported holding 39,330 shares of DNA (GINKGO BIOWORKS HOLDINGS INC) in its Q3 2026 13F filing — a position valued at US$505K, representing 0.49% of its reported portfolio and ranking #20 among its reported holdings. Q Fund Management (Hong Kong) Ltd first reported this position in Q3 2026.

Latest position (Q3 2026)39.33K sh
Reported value held$504.60K
Portfolio Weight0.49%
First reportedQ3 2026
Last changeNew
Updated2026-10-14

Last updated: 2026-10-14 · Source: SEC EDGAR Form 13F-HR

How Q Fund Management (Hong Kong) Ltd's DNA position evolved

Q Fund Management (Hong Kong) Ltd first disclosed a stake in DNA in Q3 2026 at 39,330 shares (US$505K).

Quarter by quarter

QuarterSharesValueChange
Q3 2026 39.33K $504.60K New

About DNA and 13F data

DNA (GINKGO BIOWORKS HOLDINGS INC) is a Health Care company. 33 other funds we track also report a position in DNA — the largest reported positions include Anchorage Capital Group, L.L.C. (US$17.3M), FORBES J M & CO LLP (US$12.5M), SB INVESTMENT ADVISERS (UK) LTD (US$6.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding DNA

All DNA fund holders →

FAQ

How long has Q Fund Management (Hong Kong) Ltd held DNA?

Q Fund Management (Hong Kong) Ltd has disclosed DNA holdings in 1 of the last 1 reported quarters, going back to Q3 2026.

What is Q Fund Management (Hong Kong) Ltd's current position in DNA?

As of Q3 2026, Q Fund Management (Hong Kong) Ltd holds 39.33K shares of DNA (GINKGO BIOWORKS HOLDINGS INC), valued at $504.60K, representing 0.49% of its reported portfolio and ranking #20.

Has Q Fund Management (Hong Kong) Ltd been buying or selling DNA?

In the latest 13F filing (Q3 2026), Q Fund Management (Hong Kong) Ltd newly opened its position in DNA.

Which other funds hold DNA?

Other major institutional holders of DNA include Anchorage Capital Group, L.L.C., FORBES J M & CO LLP, SB INVESTMENT ADVISERS (UK) LTD, among 33 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.